InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: jckrdu post# 47347

Wednesday, 10/23/2019 11:53:44 AM

Wednesday, October 23, 2019 11:53:44 AM

Post# of 48316
I think Merck may not be as interested in the current Tavo platform for melanoma if the borr is 17%....maybe or maybe not gets the approval....and if it does who much market penetration can Tavo see and how much real money would this equate to for Merck. The Chinese and Koreans are willing to take a loss and invest in the Next_Gen Platform which is still pre clinical....so the CGP deal is probably the best thing that will happen here in the next year.....but I do think the shares will drift lowere before a buyout is entertained. I hope a buyout does happen here and be done with this.